Changes of airway obstruction parameters in healthy children caused by mother's smoking during pregnancy

S Nosal1, P Durdik, M Sutovska

  • 1Pediatric Clinic, Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia. slavonosal@yahoo.com.

Insights

Maternal smoking during pregnancy negatively impacts infant respiratory health. Newborns exposed to smoking show altered airway obstruction parameters, particularly in infants under six months old.

Area of Science:

  • Pediatric Pulmonology
  • Environmental Health

Background:

  • Maternal smoking during pregnancy is a known risk factor for adverse child health outcomes.
  • Understanding the specific impact on early respiratory function is crucial for preventative strategies.

Purpose of the Study:

  • To assess the effect of maternal smoking during pregnancy on respiratory parameters in healthy children.
  • To investigate age-dependent differences in these effects.

Main Methods:

  • Non-calibrated respiratory inductive plethysmography was used to measure phase angle (phi) and T(me)/T(E) index.
  • 127 healthy children were divided into two age groups (<6 months and >6 months) and by maternal smoking status.

Main Results:

  • Statistically significant differences in phase angle (phi) and T(me)/T(E) were observed in infants under 6 months born to mothers who smoked compared to those born to non-smokers.
  • These differences were not significant in children over 6 months of age.
  • Within the smoking mother group, younger infants (<6 months) showed significant changes in phi and T(me)/T(E) compared to older infants (>6 months).

Conclusions:

  • Maternal smoking during pregnancy has a negative impact on infant airway obstruction parameters.
  • The effects are most pronounced in the youngest infants (under 6 months).
  • Early detection and intervention are vital for mitigating these respiratory risks.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...